Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (444)	6/25/2002 10:32:28 PM
From: Jibacoa	Read Replies (1) of 544

RIGL Apparently yesterday's patent settlement with Pharmexa, the subsidiary of Inoxell was not well received, since RIGL was down 28.10% today on more than double its daily average volume. siliconinvestor.com RIGL is trading now at less than half its April H, but it is still selling above book and above its cash/share.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next